Profile

Swapping stethoscope for pipette to understand diabetic retinopathy

Nipuna Weerasinghe
May 1, 2024

Emma M. Lessieur Contreras grew up in El Mante, Tamaulipas, Mexico, a rural township where residents farm sugarcane. The local diet is derived largely from this crop, resulting in high rates of diabetes.

As the community's only ophthalmologist, Lessieur Contreras' father treated many patients with diabetes-related vision problems. This inspired Lessieur Contreras to embark on a professional journey that took her from ophthalmology-focused medical studies in Mexico to diabetic retinopathy research in the United States.

Emma Lessieur Contreras is a postdoctoral fellow at the University of California, Irvine under the supervision of Timothy Kern, focusing on the immune system's role in diabetic retinopathy.
Emma Lessieur Contreras
Emma Lessieur Contreras is a postdoctoral fellow at the University of California, Irvine under the supervision of Timothy Kern, focusing on the immune system's role in diabetic retinopathy.

Lessieur Contreras earned her M.D. from the Universidad Autónoma de Tamaulipas. After her father's unexpected death, she moved to the U.S. looking for better opportunities to financially support her family. While overcoming the dual challenges of mastering English and validating her Mexican medical degree, she was a clinical research fellow, at the University of Texas Health Science Center at Houston, working mainly with retinal specialists.

"They were participating in the Diabetic Retinopathy Clinical Research Network, or DRCR.net, so I enrolled in those projects and moved more into the field of diabetic retinopathy," she said.

She passed the U.S. Medical Licensing Examination and moved to Ohio, where she had a clinical fellowship at the Cole Eye Institute of the Cleveland Clinic. Her job involved enrolling study patients for clinical protocols at the institute, and she also started assisting with basic research.

"I got hooked on basic research," she said. "I started learning and spending more time in the lab than in the clinic. So, at one point, and with Dr. Bela Anand-Apte encouragement, I decided to hang up my white lab coat and stethoscope ... and then I picked up the blue coat and the pipette."

After earning a Ph.D. in molecular medicine with an emphasis in ophthalmology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Lessieur Contreras began a postdoctoral fellowship at the University of California, Irvine under the supervision of Timothy Kern, who seeded her with self-confidence and courage to pursue her dream in becoming an independent investigator. Now she focuses on the immune system's role in diabetic retinopathy.

This research was the foundation of her application for a Maximizing Opportunities for Scientific and Academic Independent Careers, or MOSAIC, award. The American Society for Biochemistry and Molecular Biology MOSAIC program, funded by the National Institutes of Health, provides two years of postdoctoral funding, followed by three years of R01-level funding to launch an independent faculty career. Her MOSAIC research project focuses on how extracellular vesicles, or EVs, from the diabetic neural retina, affect the immune system.

Clare Gilbert/Community Eye Health Journal
Images showing the effects of diabetic retinopathy on the retina — such as blood vessel leakage, retinal swelling or edema and abnormal growth of new blood vessels or neovascularization.

"It is very striking to me," Lessieur Contreras said, "the different processes that occur in the retina, such as those related to the visual cycle, somehow affect the immune system. It is a distant communication — how does it occur?"

Her research has shown that EVs from mice that are pharmacologically altered to have diabetes can trigger immune cells in nondiabetic mice, inducing retinal endothelial cell death and potentially leading to capillary degeneration, which is characteristic of early diabetic retinopathy.

These results challenge the conventional view of diabetic retinopathy as a primarily vascular disease, suggesting treatment could target neurovascular interactions and immune modulation.

Lessieur Contreras is also an advocate for diversity in science, technology, engineering and mathematics, mentoring a new generation of Chicanx/Latinx students at UC Irvine with a program called the Chicano/Latino Staff Association.

She balances her research career with a family life that includes three children and a husband, Hugo Paz y Mar, who is active in academia and clinical practice.

"Keep dreaming" she advises.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Nipuna Weerasinghe

Nipuna Weerasinghe holds a bachelor’s degree in chemistry from the University of Colombo, Sri Lanka, and a master’s degree in chemistry from the University of Arizona.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

From dust to discovery
Profile

From dust to discovery

July 23, 2025

From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women’s health.

Fliesler wins scientific and ethical awards
Member News

Fliesler wins scientific and ethical awards

July 21, 2025

He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Advice

AI can be an asset, ASBMB educators say

July 9, 2025

Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.